246250 — SLS Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩36bn
- KR₩29bn
- KR₩9bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 627 | -678 | 57.9 | 2,826 | 1,434 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 695 | 2,888 | 822 | -2.93 | 1.72 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -465 | -2,789 | -21.3 | -92.4 | 722 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,995 | 678 | 2,258 | 4,034 | 3,436 |
Capital Expenditures | -667 | -1,093 | -786 | -735 | -1,409 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 962 | 551 | 4.11 | -809 | -6,510 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 294 | -541 | -782 | -1,543 | -7,918 |
Financing Cash Flow Items | — | -0.665 | -1.03 | — | -302 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,904 | -722 | -186 | -2,345 | 4,777 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 385 | -586 | 1,290 | 146 | 295 |